4 results
·
34ms
·
Sources: EU EUDAMED, US FDA
Filters
FDA Classification
×
Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia
FDA classification
FDA Class 2
·Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia
Thymidine Kinase Activity
FDA classification
FDA Class 2
·Thymidine Kinase Activity
Antiserum, Digoxin
FDA classification
FDA Class 2
·Antiserum, Digoxin
Nadh Oxidation/Nad Reduction, Alt/Sgpt
FDA classification
FDA Class 1
·Nadh Oxidation/Nad Reduction, Alt/Sgpt